home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Challenges of Running Clinical Trials for Advanced Therapies and How to Overcome Them

 
  September 18, 2024  
     
 
Xtalks, Online
2024-10-03


The rapidly evolving landscape of advanced therapies, including cell and gene therapies, presents unique challenges for small and mid-sized biotech and pharmaceutical companies.

Navigating the complexities of clinical trials in this space requires more than just technical expertise; it demands a strategic approach to partnership and resource management. In this webinar, the expert speakers will explore the specific hurdles these companies face and how collaboration with specialized service providers can drive success.

Key challenges include managing the intricate regulatory environment, ensuring patient recruitment and retention and handling the logistical complexities of these highly personalized therapies. Smaller organizations often struggle with limited resources, both in terms of personnel and infrastructure, making these trials particularly daunting.

The expert speakers will also discuss how partnering with the right pharmaceutical services provider can help overcome these obstacles. They will delve into strategies for leveraging external expertise to navigate regulatory pathways, optimize trial design and ensure efficient operational execution. The attendees will gain insights into selecting partners who can provide not only technical support but also strategic guidance, helping to reduce risks, accelerate timelines and ultimately bring life-saving therapies to market more effectively.

Register for this webinar today to understand the unique challenges of navigating clinical trials for advanced therapies and learn how strategic partnerships can help achieve successful results.

Keywords: Pharmaceutical, Drug Development, Precision Medicine, Clinical Research, Biopharma, Biotech, CRO, Patient Recruitment, Regulatory, Therapeutic Areas, Pharma, Cell & Gene Therapy, Cell & Gene Therapies, CGT
 
 
Organized by: Xtalks
Invited Speakers: Shaheen Limbada, Chief Operating Officer, WEP Clinical
Kevin Hennegan, Head of Advanced Therapies, Quantum Regulatory Solutions
 
Deadline for Abstracts: 2024-10-03
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.